Concepedia

Rong En Tay

RE

Statistics

Publications

8

Citations

1.7K

H-Index

8

Active since

2018

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Broad Institute

Massachusetts General Hospital

National University of Singapore

Rong En Tay is an author at Harvard University specializing in immunology, tumor immunology, and cancer immunology.

ORCID

Publications per year

2018–2025

8

Publications

8

A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

Deng Pan, Aya Kobayashi, Peng Jiang et al. · Science · 2018 · 864 citations

, , +16

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

Lucas Ferrari de Andrade, Rong En Tay, Deng Pan et al. · Science · 2018 · 450 citations

, , +17

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

Zohreh Amoozgar, Jonas Kloepper, Jun Ren et al. · Nature Communications · 2021 · 198 citations · Full text

, , +17

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

Sushil Kumar, Zexian Zeng, Archis Bagati et al. · Cancer Discovery · 2021 · 96 citations · Full text

, , +17

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

Rong En Tay, Olamide Olawoyin, Paloma Cejas et al. · The Journal of Experimental Medicine · 2020 · 68 citations · Full text

, , +13

1–5 of 8